# Biodel

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/biodel

- Industry: Pharmaceuticals
- Headquarters: Danbury, US
- Total disclosed funding: $21M
- Latest round: Series B (Aug 2, 2006)
- Investors on record: 3

## About

Established in 2003 and based in Connecticut, US, Biodel Inc. operates as a biopharmaceutical company that develops treatments for diabetes.

## Funding rounds

- Series B, Aug 2, 2006, $21M — OrbiMed Advisors, Vivo Capital, Great Point Partners

## Investors

- OrbiMed Advisors (https://capitalatlas.ai/funds/orbimed-advisors) — Series B
- Vivo Capital (https://capitalatlas.ai/funds/vivo-capital) — Series B
- Great Point Partners (https://capitalatlas.ai/funds/great-point-partners) — Series B